Endometriosis: The Science, The Gaslighting & What's Actually Coming with Alice Molloy
1h 9m | Sep 23, 2026🔬 In this episode I'm joined by Alice Molloy endometriosis researcher at the University of Edinburgh, research technician on the landmark Endo1000 project, and someone who started reading peer-reviewed papers at 16 from her post-surgery bed because no one would tell her what was happening in her own body.
🧬 We get into the full science, the three subtypes of endometriosis, why lesions manufacture their own local estrogen supply, progesterone receptor loss, how the immune system is actively recruited to protect lesions instead of clearing them, and why the co-occurrence of autoimmune conditions, histamine intolerance, and gut dysfunction is mechanistically predictable.
⚡ Alice breaks down what's actually coming in treatment the precision peptide just approved by the FDA for human trials, dichloroacetate and the Epic 2 randomised trial currently underway at Edinburgh, the androgen biomarker finding showing a specific 11-ketotestosterone signature in over 95% of endometriosis patients, and where the saliva microRNA test actually sits in the peer review process.
📰 We also talk about The Telegraph's "disability is trendy" article, why online chronic illness communities are a survival mechanism not a lifestyle choice, and what nine years average diagnostic delay becomes for women of colour.
Find Alice at @earthwithalice on Instagram and TikTok, and @wombdecoded for the fully referenced science content. Support or join the Endo1000 project at endo1000.com
arcwoman.com.au
🔵 Arc Woman™ content is protected by copyright and trademark laws. Reuse or repurposing requires written consent. This podcast is not a replacement for medical advice.
Advertising Inquiries: https://redcircle.com/brands
